Article
A New Venue of TNF Targeting
2018-04-02
Abstract excerpt
The first FDA-approved drugs were small, chemically-manufactured and highly active molecules with possible off-target effects. After this first successful wave of small drugs, biotechnology allowed the development of protein-based medicines such as antibodies. Conventional antibodies bind a specific protein and are becoming increasingly important in the therapeutic landscape. A very prominent class of biologicals...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 57e3dbae-26ef-5fb4-acb1-cdad7514873f
- DOI
- 10.20944/preprints201804.0015.v1
